Explaining the Implications of Friday’s Contradictory Court Rulings About the Abortion Drug Mifepristone

In separate court rulings issued late Friday, two federal judges issued contradictory rulings about an abortion drug, mifepristone, with one judge issuing a nationwide preliminary injunction that would take effect in seven days that would rescind the U.S. Food and Drug Administration’s decision to approve the drug over two decades ago, and the other barring the agency from changing its current policies.

A new post by KFF’s experts explains the implications of the dueling decisions and the potential next steps in the legal battles that could determine whether the drug remains available in states where abortion remains legal.

Journalists who want to talk to a KFF expert about this topic should email KFFMedia@kff.org.